Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
As per available reports about 56 relevant journals, 270 Conference proceedings, 78 workshops are presently dedicated exclusively to Heart medicine and about 1,270 articles are being published on Heart failure.
Heart failure also called as chronic heart failure (CHF), congestive heart failure (CHF) or congestive cardiac failure (CCF) is a physiological state in which the heart is not able to pump enough blood to meet the body's requirement. In some cases, the heart can't fill with enough blood. In other cases, the heart can't pump blood to the rest of the body with enough force. Some people have both problems.
Heart failure can be divided into two different types: heart failure due to reduced ejection fraction (HFREF) which is due to left ventricular systolic dysfunction or systolic heart failure and heart failure due to preserved ejection fraction (HFPEF) also known as diastolic heart failure or heart failure with normal ejection fraction (HFNEF). Heart failure with reduced ejection fraction occurs when the ejection fraction is less than 40%. In diastolic heart failure, the heart muscle contracts well but the ventricle does not fill with blood well in the relaxation phase. Ejection fraction is the proportion of blood in the heart pumped out of the heart during a single contraction. It is a percentage with normal being between 50 and 75%.
Heart failure symptoms are arbitrarily divided into "left" and "right" sided. Common signs for Left sided failure include shortness of breath, rales or crackles heard in the lungs due to development of pulmonary edema, cyanosis suggesting sever hypoxemia, "Cardiac asthma" or wheezing, dizziness, confusion and cool extremities at rest. Common signs for right sided failure include pitting peripheral edema, ascites, and hepatomegaly. Common causes of heart failure are Ischemic heart disease, Cigarette smoking, Hypertension , Obesity , Diabetes and disease. Heart failure can be diagnosed by Echocardiography, Electrophysiology, Blood tests, Angiography, Monitoring and Algorithms such as Framingham criteria and ESC algorithm.
Heart failure is a very common condition. Currently, heart failure has no cure. However, treatments-such as medicines and lifestyle changes-can help people who have the condition live longer and more active lives. Researchers continue to study new ways to treat heart failure and its complications. Keeping in view of the importance of Heart failure a large number of conference are being organized all over the world such as 15 in Asia like Using Biomarkers to Predict Heart Failure and for Disease Management 2014, 21 in Europe like ICI 2015 - Imaging in Cardiovascular Interventions, 42 in USA like 21st Century Treatment of Heart Failure: Synchronizing Surgical and Medical Therapies for Better Outcomes 2014.
Around 16 National symposiums and Workshops are going to be held across the globe which includes “3rd AAHFN Advanced heart failure symposium”, “LA Heart Failure Symposium - 2014”, “2014 Heart Failure Accreditation Workshops”, “CPR (cardiopulmonary resuscitation) Workshops”..
Scope of heart medicine:
In most people, heart disease develops through a lifetime of cigarettes, Trans- fats or high glycemic foods. For only a minority of patients does the cause lie in their genes. But when such atypical patients show up for treatment, figuring out why their hearts aren’t working has been a huge challenge for their doctors. The process of deciding if a heart patient’s problem is genetic and, if so, which gene defects might be causing the problem can take weeks or months, cost a thousand dollars or more, and, at the end, leaves physicians still scratching their heads over a mountain of uncertain data. Importance of heart medicine: The continuing epidemic of cardiovascular diseases (CVD) in the United States and globally calls for renewed and intensified public health action to prevent heart disease and stroke. Public health agencies at national, state, and local levels (including CDC in partnership with NIH) bear a special responsibility to meet this call, along with tribal organizations and all other interested partners. The widespread occurrence and silent progression of atherosclerosis and high blood pressure (the dominant conditions underlying heart disease and stroke) has created a CVD burden that is massive in terms of its attendant death, disability, and social and economic costs. This burden is projected to increase sharply by 2020 because of the changing age structure of the U.S. population and other factors, including the rising prevalence of obesity and diabetes. Several popular myths and misconceptions have obscured this reality, and these must be dispelled through effective communication with the public at large and with policy maker.
The global cardiovascular device industry (part of the medical devices market) is growing rapidly and exhibits signs that it will continue to evolve and expand to reach over $97 billion by 2015, up from nearly $85 billion in 2010 according to a study from BCC Research. This boom is strongly supported by a variety of heart health-related problems that are steadily increasing in number around the world: Over 80 million people suffer from cardiovascular diseases (CVDs) globally reports the American Heart Association, with more than 17 million deaths every year.
OMICS International organises 1000+ Global Events every year in Conference series, on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700+ open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.
This page will be updated regularly.
This page was last updated on 12th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising